Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice
- 1 February 2006
- Vol. 24 (7) , 989-996
- https://doi.org/10.1016/j.vaccine.2005.08.075
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of diseaseVaccine, 2005
- Protection Afforded by Heat Shock Protein 60 fromFrancisella tularensisIs Due to Copurified LipopolysaccharideInfection and Immunity, 2004
- TularemiaClinical Microbiology Reviews, 2002
- Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide productionMolecular Microbiology, 1996
- Immunogenicity of a new lot ofFrancisella tularensislive vaccine strain in human volunteersFEMS Immunology & Medical Microbiology, 1996
- Francisella tularensisresistance to bactericidal action of normal human serumFEMS Immunology & Medical Microbiology, 1996
- Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic mediumVaccine, 1994
- The tularaemia vaccineJournal of Chemical Technology & Biotechnology, 1994
- Immunogenicity and toxicity of lipopolysaccharide fromFrancisella tularensisLVSFEMS Microbiology Letters, 1992
- Immunization against Tularemia: Analysis of the Effectiveness of Live Francisella tularensis Vaccine in Prevention of Laboratory-Acquired TularemiaThe Journal of Infectious Diseases, 1977